BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Adhezion Biomedical Announces CE Mark Approval of Film-Forming Microbial Sealant FloraSeal


1/15/2009 6:25:23 AM

WYOMISSING, Pa.--(BUSINESS WIRE)--Adhezion Biomedical LLC announced today that it received European CE Mark (Conformité Européene) approval for FloraSeal, a film-forming, cyanoacrylate-based microbial sealant in a ready-to-use applicator. CE is a mandatory European marking that indicates conformity with the essential health and safety requirements set out in European Directives.

FloraSeal is designed to help reduce the incidence of surgical site infections, a health care-associated infection (HAI). The World Health Organization (WHO) estimates that surgical site infections account for about 25% of HAIs. The burden of disease attributable to HAIs is huge, with hundreds of millions of patients affected worldwide every year. These infections contribute to patient deaths and disability, and promote resistance to antibiotics.1

This is the second Adhezion Biomedical product to receive CE Mark approval. In February 2008, the CE Mark was awarded for SurgiSeal™ Topical Skin Adhesive, which also recently received FDA clearance to market in the U.S. Adhezion Biomedical’s proprietary formulation can be used in a variety of applications, including as an advanced microbial surgical sealant designed to create a protective barrier to immobilize bacteria and other pathogens. Other applications include topical skin adhesives designed to replace sutures, staples and bandages. The products require no refrigeration or blending, dry quickly and are very flexible. They are sold under the FloraSeal and SurgiSeal brands, targeted to surgeons and physicians.

“Having the CE Mark for FloraSeal will create great opportunities for us in the European market,” said Pete Molinaro, CEO of Adhezion Biomedical. “The CE Mark is recognized globally as an indicator of high product quality and good manufacturing practices. We are currently entering distribution agreements around the globe for FloraSeal and SurgiSeal.”

About Adhezion Biomedical LLC

Adhezion Biomedical is a privately held medical device company based in Wyomissing, PA. Adhezion is committed to developing and manufacturing adhesive and anti-microbial sealant products that are both highly differentiated and proprietary. To learn more, visit www.adhezion.com.

1 Source: Global Patient Safety Challenge data, 2005 WHO Guidelines on Hand Hygiene in Health Care (Advanced Draft): A Summary, 2005 http://www.who.int/patientsafety/events/06/CC_factsheet.pdf.

Contact:

Adhezion Biomedical LLC Investors Pete Molinaro, 484-334-2929, Ext. 301 pmolinaro@adhezion.com or Media Manny Rodriguez, 484-334-2929, Ext. 302 mrodriguez@adhezion.com

Source: Adhezion Biomedical LLC

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->